Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 4, 2010

View Archived Issues

Cornerstone and Alitair collaborate on drug development for respiratory diseases

Ajinomoto claims new inhibitors of IL-12/IL-23 production

ArQule discloses new FGFR inhibitors

Taisho discovers new DP2 receptor antagonists

Japanese researchers describe new KIF11 inhibitors

IGFBP-7 mediates oncogene-induced senescence in papillary thyroid carcinoma

DAB2IP gene SNP correlates with susceptibility to abdominal aortic aneurism

Regadenoson SPECT is safe and tolerated in patients with CKD and ESRD

TBR-652 exhibits potent anti-HIV activity in phase II trial

Nanobin encapsulation improves therapeutic efficacy of As2O3 in solid tumors

Lexicon reacquires rights to several serotonin synthesis inhibitors from Symphony Icon

Merck & Co. identifies new gamma-secretase modulators

Mallinckrodt claims novel diagnostic agents for renal disorders

FDA clears first-in-human trial of N-6022

Seattle Genetics and Genentech expand antibody-drug conjugate agreement

Diamyd receives upfront payment from OMJP under Diamyd collaboration

Oxygen signs CRADA with U.S. navy to study decompression sickness therapy

FusoGen presents phase IIb data on sifuvirtide in HIV

Pharmachem Laboratories offers to acquire all assets from Forbes Medi-Tech

First patient receives treatment in phase Ib expansion trial of CUDC-101

Patient enrollment advances ahead of schedule in phase III Probuphine trial

Northwest reports phase I/II data on DCVax-Brain personalized immune therapy

MiddleBrook Pharmaceuticals completes sale of assets to Victory Pharma

Mitsubishi Tanabe transfers Kerlong marketing rights to sanofi-aventis

Taisho Pharma discontinues development of TS-022 for atopic dermatitis with pruritus

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...